Regulations.gov document
Bhat, R. S., Alonazi, M., Al-Daihan, S., & El-Ansary, A. (2023). Prenatal SSRI exposure…
Supporting & Related Material · FDA-2025-P-3956 · posted Sep 23, 2025
Key facts
| Document ID | FDA-2025-P-3956-0016 |
|---|---|
| Title | Bhat, R. S., Alonazi, M., Al-Daihan, S., & El-Ansary, A. (2023). Prenatal SSRI exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain. Metabolites, 13(2), 310. https://doi.org/10.3390/metabo13020310 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2025-P-3956 |
| Posted | Sep 23, 2025 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: